Bavarian Nordic A/S (OMX: BAVA) today announced that Health Canada has approved VIMKUNYA® (recombinant, adsorbed) for ...
The CDC's Advisory Committee on Immunization Practices (ACIP) unanimously recommended that U.S. travelers ages 12 years and older receive the virus-like particle chikungunya vaccine (Vimkunya) when ...
Breakthrough directed evolution system boosts virus-like particles for safer, more efficient gene editing, offering a powerful tool for next-generation therapeutic innovations. Study: Directed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results